Sapiens International Corporation NV
NASDAQ:SPNS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
25.47
41.02
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sapiens International Corporation NV
Sapiens International Corporation NV
Research & Development
Sapiens International Corporation NV
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sapiens International Corporation NV
NASDAQ:SPNS
|
Research & Development
-$65.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-19%
|
|
|
Walkme Ltd
NASDAQ:WKME
|
Research & Development
-$55.1m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
Nice Ltd
TASE:NICE
|
Research & Development
-$340.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-10%
|
|
|
Cellebrite DI Ltd
NASDAQ:CLBT
|
Research & Development
-$84.4m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Hilan Ltd
TASE:HLAN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Similarweb Ltd
NYSE:SMWB
|
Research & Development
-$56.2m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
Sapiens International Corporation NV
Glance View
Sapiens International Corp. NV provides software solutions for the insurance industry. The firm operates in provider of software solutions segment. Its software solutions portfolio consists of Life, Pension, Annuity and Retirement Solutions, including software solutions for the management of a range of products for life, pension, annuity and retirement; Property and Casualty/General Insurance Solutions, including a software suite of solutions, supporting a range of business lines, including personal, commercial and specialty lines, as well as a solution for the management of reinsurance contracts; Sapiens DECISION, which is a business decision management solution, and Technology-Based Solutions, such as Sapiens eMerge. Its services include project delivery and implementation, business and technical consulting related to its products, project and program management, training and user acceptance testing.
See Also
What is Sapiens International Corporation NV's Research & Development?
Research & Development
-65.9m
USD
Based on the financial report for Sep 30, 2024, Sapiens International Corporation NV's Research & Development amounts to -65.9m USD.
What is Sapiens International Corporation NV's Research & Development growth rate?
Research & Development CAGR 10Y
-19%
Over the last year, the Research & Development growth was -5%. The average annual Research & Development growth rates for Sapiens International Corporation NV have been -9% over the past three years , -13% over the past five years , and -19% over the past ten years .
You don't have any saved screeners yet
